Exciting News! epipole are officially members of Fife Chamber of Commerce! 🙌
Sarah Jardine, CEO of epipole says “We are thrilled to join the local Chamber as part of our continuing efforts to develop relationships with the local business community.
Our heartfelt gratitude to everyone who attended the SECO event last week – what an amazing show!!
We were overwhelmed with the positive feedback received for the epiCam, with a number of you getting first-hand chance to see for yourself the future of handheld optometry, and it was truly inspiring to hear your thoughts and opinions about our latest offering 👏
epipole are celebrating the appointment of our new CEO… By sending her to the other side of the planet!
Sarah (Jardine) will be joining our US Sales Team at the SECO event this week in Atlanta, where the team will be exhibiting our fantastic epiCam product at the show!
Global Launch of New Ultra-Portable Fundus Camera, from epipole, at Vision Expo East (NYC)
epiCam: the functionality of desktop retinal imaging, in the palm of your hand
epipole joins €1.1m AI project to diagnose intracranial pressure
epipole and Danish partners secure Eurostars grant funding to integrate handheld video ophthalmoscope technology with intracranial pressure measurement software
epipole secures £1.5 million investment
epipole has secured £1.5 million in funding to market its ground-breaking video retinal imaging device in the US. The funding round was led by new investor Greenwood Way Capital with the Scottish Investment Bank, the investment arm of Scottish Enterprise, also participating.
epipole wins ophthalmology innovation challenge
epipole were selected as one of the five finalists in Novartis’ Biome 2019 Ophthalmology Innovation Challenge in their San Francisco Biome headquarters. Among stiff competition from companies that presented their deeply innovative technology the six American Academy of Ophthalmology judges were unanimous in awarding epipole with the first prize of $6000. After a standing ovation […]
epipole secures £1.5 million investment
epipole founder Craig Robertson discusses the history of the company and the challenges of balancing ‘doing the right thing’ with running a sustainable business in the latest edition of The Ophthalmologist.